Showing results (891-900 of 1,351) with videos related to
Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|June 17, 2016
Lung Delivery of Indacaterol and Mometasone Furoate Following Inhalation of QMF149 in Healthy VolunteersSoniya S Vaidya, Sanjeev Khindri, Suzanne Maahs, et al.Clinical Pharmacology in Drug Development|July 2, 2016
Single- and Multiple-Dose Pharmacokinetics of Immediate-Release/Extended-Release Ibuprofen TabletsThomas Legg, Edward Paluch, Shyamalie JayawardenaClinical Pharmacology in Drug Development|July 2, 2016
Dose-Dependent Effect of Piragliatin, a Glucokinase Activator, on the QT Interval Following Short-Term Multiple Doses in Patients With Type 2 Diabetes MellitusJianguo Zhi, Suoping Zhai, Mark BoldrinClinical Pharmacology in Drug Development|December 12, 2017
Population Pharmacokinetics of Desvenlafaxine: Pharmacokinetics in Korean Versus US PopulationsAlice I Nichols, Sam Liao, Richat AbbasClinical Pharmacology in Drug Development|January 11, 2018
Clinical Bioavailability of the Novel BACE1 Inhibitor Lanabecestat (AZD3293): Assessment of Tablet Formulations Versus an Oral Solution and the Impact of Gastric pH on PharmacokineticsNaidong Ye, Scott A Monk, Pankaj Daga, et al.Clinical Pharmacology in Drug Development|February 9, 2018
Pharmacokinetics and Safety of Risperidone Subcutaneous Implants in Stable Patients With SchizophreniaRyan Dammerman, Sonnie Kim, Mathews Adera, et al.Clinical Pharmacology in Drug Development|May 4, 2018
Does Dapagliflozin Affect Energy Intake and Appetite? A Randomized, Controlled Exploratory Study in Healthy SubjectsElizabeth Bertran, Helen D Berlie, Aaron Nixon, et al.Clinical Pharmacology in Drug Development|July 26, 2018
Amenamevir: Studies of Potential CYP3A-Mediated Pharmacokinetic Interactions With Midazolam, Cyclosporine, and Ritonavir in Healthy VolunteersTemitope Adeloye, Omair Sahgal, Adeep Puri, et al.Clinical Pharmacology in Drug Development|July 31, 2018
Relative Bioavailability and Food Effect Evaluation for 2 Tablet Formulations of Asciminib in a 2-Arm, Crossover, Randomized, Open-Label Study in Healthy VolunteersHans D Menssen, Michelle Quinlan, Charisse Kemp, et al.Clinical Pharmacology in Drug Development|July 31, 2018
Bioequivalence of Olanzapine Given in Combination With Samidorphan as a Bilayer Tablet (ALKS 3831) Compared With Olanzapine-Alone Tablets: Results From a Randomized, Crossover Relative Bioavailability StudyLei Sun, David McDonnell, Jianjun Liu, et al.Pageof 136